Multimedialna platforma wiedzy medycznej Internetowa Księgarnia Medyczna Kalendarium Konferencji
Nowotwory. Journal of Oncology
MENU
Shortcuts Submit an article Author Guidelines Ahead Of Print Editorial Office Manuscript Submission Reviewers 2023 Best Original Paper Award

open access

Vol 73, No 3 (2023)
Review paper
Published online: 2023-05-11
View PDF Download PDF file View HTML
Get Citation

Novel tobacco and nicotine products and youth in the European Union

Ariadna Feliu1, Carolina Espina1, Cristina Martinez23456, Esteve Fernandez2345
DOI: 10.5603/NJO.a2023.0022
·
Nowotwory. Journal of Oncology 2023;73(3):162-167.
Affiliations
  1. Environment and Lifestyle Epidemiology Branch, International Agency for Research on Cancer, Lyon, France
  2. Tobacco Control Unit, Cancer Prevention and Control Program, Institut Català d’Oncologia, Barcelona, Spain
  3. Tobacco Control Research Group, Institut d’Investigació Biomèdica de Bellvitge, Barcelona, Spain
  4. School of Medicine and Health Sciences,Universitat de Barcelona, Barcelona, Spain
  5. Center for Biomedical Research in Respiratory Diseases, Madrid, Spain
  6. Philip R. Lee Institute for Health Policy Studies, University of California San Francisco, San Francisco, United States

open access

Vol 73, No 3 (2023)
Cancer prevention and public health
Published online: 2023-05-11

Abstract

In recent years, there has been a rapid proliferation of novel tobacco and nicotine products in the market, which have gained in popularity among adolescents. The prevalence of ever users of electronic cigarettes (e-cigs) in Europe among those aged 10–24 ranges from 5.5% to 56.6%, with significant variations across countries. Adolescents have reported several reasons for e-cig use initiation, including low harm perception, social acceptability, novelty, and peer influence. Despite being marketed as safe alternatives, e-cigs are not risk-free and have already been associated with respiratory diseases. A major concern is their potential to renormalize smoking among non-smokers and to foster nicotine dependence, leading to the initiation of conventional cigarette smoking, which would reverse actual declining trends in tobacco consumption. Hence, to prevent a setback on the progress made in tobacco control, there is a pressing need for more comprehensive regulation, with a particular focus on adolescents, given that the teenage years are pivotal in determining future smoking behavior.

Abstract

In recent years, there has been a rapid proliferation of novel tobacco and nicotine products in the market, which have gained in popularity among adolescents. The prevalence of ever users of electronic cigarettes (e-cigs) in Europe among those aged 10–24 ranges from 5.5% to 56.6%, with significant variations across countries. Adolescents have reported several reasons for e-cig use initiation, including low harm perception, social acceptability, novelty, and peer influence. Despite being marketed as safe alternatives, e-cigs are not risk-free and have already been associated with respiratory diseases. A major concern is their potential to renormalize smoking among non-smokers and to foster nicotine dependence, leading to the initiation of conventional cigarette smoking, which would reverse actual declining trends in tobacco consumption. Hence, to prevent a setback on the progress made in tobacco control, there is a pressing need for more comprehensive regulation, with a particular focus on adolescents, given that the teenage years are pivotal in determining future smoking behavior.

Full Text:

View PDF Download PDF file View HTML
Get Citation

Keywords

tobacco; novel products; youth; European Union; tobacco control

About this article
Title

Novel tobacco and nicotine products and youth in the European Union

Journal

Nowotwory. Journal of Oncology

Issue

Vol 73, No 3 (2023)

Article type

Review paper

Pages

162-167

Published online

2023-05-11

Page views

1444

Article views/downloads

358

DOI

10.5603/NJO.a2023.0022

Bibliographic record

Nowotwory. Journal of Oncology 2023;73(3):162-167.

Keywords

tobacco
novel products
youth
European Union
tobacco control

Authors

Ariadna Feliu
Carolina Espina
Cristina Martinez
Esteve Fernandez

References (50)
  1. WHO Regional Office for Europe. Tobacco: data and statistics. https://www.who.int/europe/news-room/fact-sheets/item/tobacco (14.02.2023).
  2. Willemsen MC, Mons U, Fernández E. Tobacco control in Europe: progress and key challenges. Tob Control. 2022; 31(2): 160–163.
    CrossRefPubMed
  3. Feliu A, Filippidis FT, Joossens L, et al. Impact of tobacco control policies on smoking prevalence and quit ratios in 27 European Union countries from 2006 to 2014. Tob Control. 2019; 28(1): 101–109.
    CrossRefPubMed
  4. Schaap MM, Kunst AE, Leinsalu M, et al. Effect of nationwide tobacco control policies on smoking cessation in high and low educated groups in 18 European countries. Tob Control. 2008; 17(4): 248–255.
    CrossRefPubMed
  5. World Health Organization. WHO Framework Convention on Tobacco Control. Geneva: 2003. http://www.who.int/tobacco/framework/WHO_FCTC_english.pdf (7.05.2017).
  6. Joossens L, Olefir L, Feliu A, et al. The Tobacco Control Scale 2021 in Europe. Brussels: 2022. http://www.tobaccocontrolscale.org/TCS2021 (20.02.2023).
  7. European Commission. Special Eurobarometer 272c Report: Attitudes of Europeans towards Tobacco. Brussels: 2007.
  8. European Commission. Attitudes of Europeans towards tobacco and electronic cigarettes. Brussels: 2021. https://europa.eu/eurobarometer/surveys/detail/2240 (20.02.2023).
  9. O'Connor R, Schneller LM, Felicione NJ, et al. Evolution of tobacco products: recent history and future directions. Tob Control. 2022; 31(2): 175–182.
    CrossRefPubMed
  10. Tehrani H, Rajabi A, Ghelichi-Ghojogh M, et al. The prevalence of electronic cigarettes vaping globally: a systematic review and meta-analysis. Arch Public Health. 2022; 80(1): 240.
    CrossRefPubMed
  11. Gentzke AS, Wang TW, Cornelius M, et al. Tobacco Product Use and Associated Factors Among Middle and High School Students - National Youth Tobacco Survey, United States, 2021. MMWR Surveill Summ. 2022; 71(5): 1–29.
    CrossRefPubMed
  12. Perikleous EP, Steiropoulos P, Paraskakis E, et al. E-Cigarette Use Among Adolescents: An Overview of the Literature and Future Perspectives. Front Public Health. 2018; 6: 86.
    CrossRefPubMed
  13. Aly AS, Mamikutty R, Marhazlinda J. Association between Harmful and Addictive Perceptions of E-Cigarettes and E-Cigarette Use among Adolescents and Youth-A Systematic Review and Meta-Analysis. Children (Basel). 2022; 9(11).
    CrossRefPubMed
  14. European Parliament and the Council. Europe’s Beating Cancer Plan Brussels, 2021.
  15. Filippidis FT, Laverty AA, Gerovasili V, et al. Two-year trends and predictors of e-cigarette use in 27 European Union member states. Tob Control. 2017; 26(1): 98–104.
    CrossRefPubMed
  16. Karim MA, Talluri R, Chido-Amajuoyi OG, et al. Awareness of heated tobacco products among US Adults - Health information national trends survey, 2020. Subst Abus. 2022; 43(1): 1023–1034.
    CrossRefPubMed
  17. Tabuchi T, Gallus S, Shinozaki T, et al. Heat-not-burn tobacco product use in Japan: its prevalence, predictors and perceived symptoms from exposure to secondhand heat-not-burn tobacco aerosol. Tob Control. 2018; 27(e1): e25–e33.
    CrossRefPubMed
  18. Yi J, Lee CM, Hwang SS, et al. Prevalence and predictors of heated tobacco products use among male ever smokers: results from a Korean longitudinal study. BMC Public Health. 2021; 21(1): 316.
    CrossRefPubMed
  19. Gallus S, Lugo A, Liu X, et al. TackSHS Project Investigators. Use and Awareness of Heated Tobacco Products in Europe. J Epidemiol. 2022; 32(3): 139–144.
    CrossRefPubMed
  20. Laverty AA, Vardavas CI, Filippidis FT. Prevalence and reasons for use of Heated Tobacco Products (HTP) in Europe: an analysis of Eurobarometer data in 28 countries. Lancet Reg Health Eur. 2021; 8: 100159.
    CrossRefPubMed
  21. Kapan A, Stefanac S, Sandner I, et al. Use of Electronic Cigarettes in European Populations: A Narrative Review. Int J Environ Res Public Health. 2020; 17(6).
    CrossRefPubMed
  22. Hughes K, Bellis MA, Hardcastle KA, et al. Associations between e-cigarette access and smoking and drinking behaviours in teenagers. BMC Public Health. 2015; 15: 244.
    CrossRefPubMed
  23. Wężyk-Caba I, Kaleta D, Zajdel R, et al. Do Young People Perceive E-Cigarettes and Heated Tobacco as Less Harmful Than Traditional Cigarettes? A Survey from Poland. Int J Environ Res Public Health. 2022; 19(22).
    CrossRefPubMed
  24. National Institute for Health and Care Excellence. Tobacco: preventing uptake, promoting quitting and treating dependence NICE guideline-and-conditions#notice-of-rights Your responsibility. London: 2021. www.nice.org.uk/guidance/ng209 (9.05.2023).
  25. O'Connor RJ, Giovino GA, Kozlowski LT, et al. Changes in nicotine intake and cigarette use over time in two nationally representative cross-sectional samples of smokers. Am J Epidemiol. 2006; 164(8): 750–759.
    CrossRefPubMed
  26. Hallingberg B, Maynard OM, Bauld L, et al. Have e-cigarettes renormalised or displaced youth smoking? Results of a segmented regression analysis of repeated cross sectional survey data in England, Scotland and Wales. Tob Control. 2020; 29(2): 207–216.
    CrossRefPubMed
  27. Cao D, Aldy K, Hsu S, et al. Review of Health Consequences of Electronic Cigarettes and the Outbreak of Electronic Cigarette, or Vaping, Product Use-Associated Lung Injury. J Med Toxicol. 2020; 16(3): 295–310.
    CrossRef
  28. Goriounova NA, Mansvelder HD. Short- and long-term consequences of nicotine exposure during adolescence for prefrontal cortex neuronal network function. Cold Spring Harb Perspect Med. 2012; 2(12): a012120.
    CrossRefPubMed
  29. Fernández E, Ballbè M, Sureda X, et al. Particulate Matter from Electronic Cigarettes and Conventional Cigarettes: a Systematic Review and Observational Study. Curr Environ Health Rep. 2015; 2(4): 423–429.
    CrossRefPubMed
  30. Amalia B, Liu X, Lugo A, et al. TackSHS Project Investigators. Exposure to secondhand aerosol of electronic cigarettes in indoor settings in 12 European countries: data from the TackSHS survey. Tob Control. 2021; 30(1): 49–56.
    CrossRefPubMed
  31. Amalia B, Fu M, Tigova O, et al. TackSHS Project Investigators. Exposure to secondhand aerosol from electronic cigarettes at homes: A real-life study in four European countries. Sci Total Environ. 2022 [Epub ahead of print]: 158668.
    CrossRefPubMed
  32. Ballbè M, Martínez-Sánchez JM, Sureda X, et al. Cigarettes vs. e-cigarettes: Passive exposure at home measured by means of airborne marker and biomarkers. Environ Res. 2014; 135: 76–80.
    CrossRefPubMed
  33. McKelvey K, Baiocchi M, Halpern-Felsher B. PMI's heated tobacco products marketing claims of reduced risk and reduced exposure may entice youth to try and continue using these products. Tob Control. 2020; 29(e1): e18–e24.
    CrossRefPubMed
  34. Nicksic NE, Snell LM, Barnes AJ. Reasons to use e-cigarettes among adults and youth in the Population Assessment of Tobacco and Health (PATH) study. Addict Behav. 2019; 93: 93–99.
    CrossRefPubMed
  35. Xu SS, Meng G, Yan Mi, et al. Reasons for Regularly Using Heated Tobacco Products among Adult Current and Former Smokers in Japan: Finding from 2018 ITC Japan Survey. Int J Environ Res Public Health. 2020; 17(21).
    CrossRefPubMed
  36. McKelvey K, Popova L, Kim M, et al. Heated tobacco products likely appeal to adolescents and young adults. Tob Control. 2018; 27(Suppl 1): s41–s47.
    CrossRefPubMed
  37. O'Brien D, Long J, Quigley J, et al. Association between electronic cigarette use and tobacco cigarette smoking initiation in adolescents: a systematic review and meta-analysis. BMC Public Health. 2021; 21(1): 954.
    CrossRefPubMed
  38. Dewhirst T. Co-optation of harm reduction by Big Tobacco. Tob Control. 2021; 30(e1): e1–e3.
    CrossRefPubMed
  39. Adermark L, Galanti MR, Ryk C, et al. Prospective association between use of electronic cigarettes and use of conventional cigarettes: a systematic review and meta-analysis. ERJ Open Res. 2021; 7(3).
    CrossRefPubMed
  40. Moore G, Hewitt G, Evans J, et al. Electronic-cigarette use among young people in Wales: evidence from two cross-sectional surveys. BMJ Open. 2015; 5(4): e007072.
    CrossRefPubMed
  41. Sæbø G, Scheffels J. Assessing notions of denormalization and renormalization of smoking in light of e-cigarette regulation. Int J Drug Policy. 2017; 49: 58–64.
    CrossRefPubMed
  42. Sharma A, McCausland K, Jancey J. Adolescent's Health Perceptions of E-Cigarettes: A Systematic Review. Am J Prev Med. 2021; 60(5): 716–725.
    CrossRefPubMed
  43. Wilson S, Partos T, McNeill A, et al. Harm perceptions of e-cigarettes and other nicotine products in a UK sample. Addiction. 2019; 114(5): 879–888.
    CrossRefPubMed
  44. Cooper M, Loukas A, Case KR, et al. A longitudinal study of risk perceptions and e-cigarette initiation among college students: Interactions with smoking status. Drug Alcohol Depend. 2018; 186: 257–263.
    CrossRefPubMed
  45. WHO report on the global tobacco epidemic 2021: addressing new and emerging products. Geneva: 2021. https://www.who.int/publications/i/item/9789240032095 (2.08.2022).
  46. Amalia B, Fu M, Feliu A, et al. Regulation of Electronic Cigarette Use in Public and Private Areas in 48 Countries Within the WHO European Region: A Survey to In-country Informants. J Epidemiol. 2022; 32(3): 131–138.
    CrossRefPubMed
  47. European Parliament, Council. Tobacco Products Directive. European Union: 2014.
  48. Vardavas CI. European Tobacco Products Directive (TPD): current impact and future steps. Tob Control. 2022; 31(2): 198–201.
    CrossRefPubMed
  49. Straarup MS, O'Donovan F, Lambrou A, et al. The Joint Action on Tobacco Control: A cooperation project for strengthening tobacco control in Europe. Tob Prev Cessat. 2022; 8: 26.
    CrossRefPubMed
  50. Peruga A, Rodríguez Lozano F, López MJ, et al. [Tobacco heated products: a new challenge in tobacco control]. Gac Sanit. 2022; 36(1): 57–59.
    CrossRefPubMed

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl